balance equationreview2018-07-28
Difference 5955000 exceeds tolerance 2964472.000. Presentation or filing-vintage differences need review.
Revenue
$31.15B
Fiscal year ended 2026-08-01Operating income
$211.00M
Fiscal year ended 2026-08-01Free cash flow
$323.00M
Fiscal year ended 2026-08-01UNITED NATURAL FOODS INC (UNFI) reported revenue of $31.15B and net income of $84.00M for the fiscal year ended 2026-08-01. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from UNITED NATURAL FOODS INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Wholesale-Groceries, General Line.
Income
| Metric | 2026-08-01 | 2025-08-02 | 2024-08-03 | 2023-07-29 | 2022-07-30 | 2021-07-31 | 2020-08-01 | 2019-08-03 | 2018-07-28 | 2017-07-29 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $31.15B | $31.78B | $30.98B | $30.27B | $28.93B | $26.95B | $26.56B | $22.34B | $10.23B | $9.27B |
| Cost of revenue | $26.96B | $27.56B | $26.78B | $26.14B | $24.75B | $23.01B | $22.67B | $19.12B | $8.71B | $7.85B |
| Gross profit | $4.20B | $4.22B | $4.20B | $4.13B | $4.18B | $3.94B | $3.89B | $3.22B | $1.52B | $1.43B |
| Operating income | $211.00M | -$31.00M | $8.00M | $120.00M | $423.00M | $294.00M | -$193.00M | -$196.00M | $224.47M | $226.02M |
| Net income | $84.00M | -$118.00M | -$112.00M | $24.00M | $248.00M | $149.00M | -$274.00M | -$285.00M | $162.78M | $130.16M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 62.80M | shares 60.20M | shares 59.30M | shares 60.70M | shares 61.00M | shares 60.00M | shares 53.80M | shares 51.20M | shares 50.84M | shares 50.78M |
| Pretax income | $102.00M | -$154.00M | -$137.00M | $7.00M | $310.00M | $183.00M | -$342.00M | -$341.00M | $209.99M | $214.42M |
| Income tax expense | $18.00M | -$39.00M | -$27.00M | -$23.00M | $56.00M | $34.00M | -$91.00M | -$59.00M | $47.22M | $84.27M |
| Diluted EPS | $1.34 | $-1.95 | $-1.89 | $0.40 | $4.07 | $2.48 | $-5.10 | $-5.56 | $3.20 | $2.56 |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-08-01 | 2025-08-02 | 2024-08-03 | 2023-07-29 | 2022-07-30 | 2021-07-31 | 2020-08-01 | 2019-08-03 | 2018-07-28 | 2017-07-29 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $37.00M | $44.00M | $40.00M | $37.00M | $44.00M | $41.00M | $47.00M | $44.47M | $23.32M | $15.41M |
| Total assets | $7.11B | $7.60B | $7.53B | $7.39B | $7.63B | $7.52B | $7.59B | $7.17B | $2.96B | $2.89B |
| Current assets | $3.14B | $3.42B | $3.40B | $3.46B | $3.80B | $3.55B | $3.70B | $3.56B | $1.79B | $1.66B |
| Total liabilities | $5.49B | $6.04B | $5.89B | $5.65B | $5.84B | $6.01B | $6.44B | $5.67B | $1.12B | $1.20B |
| Current liabilities | $2.44B | $2.60B | $2.36B | $2.40B | $2.42B | $2.49B | $2.37B | $2.11B | $699.22M | $703.99M |
| Total equity incl. NCI | $1.62B | $1.55B | $1.64B | $1.74B | $1.79B | $1.51B | $1.14B | $1.50B | $1.84B | $1.68B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $1.95B | $2.10B | $2.18B | $2.29B | $2.36B | $2.25B | $2.28B | $2.19B | $1.14B | $1.03B |
| Accounts receivable | $889.00M | $1.06B | $936.00M | $887.00M | $1.21B | $1.12B | $1.16B | $1.06B | $595.70M | $525.64M |
| Goodwill | $19.00M | $19.00M | $19.00M | $20.00M | $20.00M | $20.00M | $20.00M | $442.00M | $362.50M | $371.26M |
| Long-term debt | $1.56B | $1.86B | $2.08B | $1.96B | $2.11B | $2.18B | $2.43B | $2.82B | $308.84M | $149.86M |
| Accounts payable | $1.77B | $1.88B | $1.69B | $1.78B | $1.74B | $1.64B | $1.63B | $1.53B | $517.12M | $534.62M |
Cash flow
| Metric | 2026-08-01 | 2025-08-02 | 2024-08-03 | 2023-07-29 | 2022-07-30 | 2021-07-31 | 2020-08-01 | 2019-08-03 | 2018-07-28 | 2017-07-29 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $540.00M | $470.00M | $253.00M | $624.00M | $331.00M | $614.00M | $457.00M | $285.00M | $109.04M | $273.33M |
| Capital expenditures | $217.00M | $231.00M | $345.00M | $323.00M | $251.00M | $310.00M | $173.00M | $228.00M | $44.61M | $56.11M |
| Investing cash flow | -$169.00M | -$218.00M | -$342.00M | -$339.00M | -$49.00M | -$237.00M | -$1.00M | -$2.26B | -$47.00M | -$59.96M |
| Financing cash flow | -$377.00M | -$248.00M | $92.00M | -$292.00M | -$279.00M | -$384.00M | -$453.00M | $2.00B | -$53.56M | -$217.12M |
| Net change in cash | -$7.00M | $4.00M | $3.00M | -$7.00M | $3.00M | -$6.00M | $2.00M | $22.00M | $7.90M | -$3.18M |
| Stock-based compensation | $61.00M | $43.00M | $39.00M | $38.00M | $44.00M | $45.00M | $25.00M | $26.00M | $25.78M | $25.68M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | $50.00M | $0 | $0 | $62.00M | $0 | $0 | $0 | $0 | $24.23M | $0 |
| Depreciation & amortization | $303.00M | $321.00M | $319.00M | $304.00M | $285.00M | $285.00M | $282.00M | $248.00M | $87.63M | $86.05M |
Derived
| Metric | 2026-08-01 | 2025-08-02 | 2024-08-03 | 2023-07-29 | 2022-07-30 | 2021-07-31 | 2020-08-01 | 2019-08-03 | 2018-07-28 | 2017-07-29 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $323.00M | $239.00M | -$92.00M | $301.00M | $80.00M | $304.00M | $284.00M | $57.00M | $64.43M | $217.22M |
| Gross margin | 13.5% | 13.3% | 13.6% | 13.6% | 14.5% | 14.6% | 14.6% | 14.4% | 14.9% | 15.4% |
| Operating margin | 0.7% | -0.1% | 0.0% | 0.4% | 1.5% | 1.1% | -0.7% | -0.9% | 2.2% | 2.4% |
| FCF margin | 1.0% | 0.8% | -0.3% | 1.0% | 0.3% | 1.1% | 1.1% | 0.3% | 0.6% | 2.3% |
| SBC / revenue | 0.2% | 0.1% | 0.1% | 0.1% | 0.2% | 0.2% | 0.1% | 0.1% | 0.3% | 0.3% |
| Current ratio | 1.29x | 1.32x | 1.44x | 1.44x | 1.57x | 1.43x | 1.56x | 1.69x | 2.56x | 2.36x |
| Revenue YoY growth | -2.0% | 2.6% | 2.3% | 4.6% | 7.3% | 1.5% | 18.9% | 118.5% | 10.3% | Unavailable |
| Net margin | 0.3% | -0.4% | -0.4% | 0.1% | 0.9% | 0.6% | -1.0% | -1.3% | 1.6% | 1.4% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 0.7% | 0.7% | 1.1% | 1.1% | 0.9% | 1.2% | 0.7% | 1.0% | 0.4% | 0.6% |
| Long-term debt / equity | 0.96x | 1.20x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 17.6% | Unavailable | Unavailable | -328.6% | 18.1% | 18.6% | Unavailable | Unavailable | 22.5% | 39.3% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open UNFI in the interactive workspace to inspect any figure back to its filing.
Source filings
10-K · Filed 2026-09-14View SEC filing
10-Q · Filed 2026-06-09View SEC filing
10-Q · Filed 2026-03-10View SEC filing
10-Q · Filed 2025-12-02View SEC filing
10-K · Filed 2025-10-01View SEC filing
10-Q · Filed 2025-06-10View SEC filing
Reconciliation checks needing review
2 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
balance equationreview2017-07-29
Difference 3996000 exceeds tolerance 2886563.000. Presentation or filing-vintage differences need review.